Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan
- 1 October 1992
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 124 (4), 1017-1025
- https://doi.org/10.1016/0002-8703(92)90986-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group.Circulation, 1990
- Pulmonary artery pressure and activities in chronic heart failureJournal of the American College of Cardiology, 1990
- Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failureThe American Journal of Cardiology, 1989
- Disparity between improvement in left ventricular function and changes in clinical status and exercise capacity during chronic enoximone therapyAmerican Heart Journal, 1989
- Analysis of quality of life data from a randomized, placebo-controlled heart-failure trialJournal of Clinical Epidemiology, 1988
- SYMPTOMATIC ASSESSMENT OF PATIENTS WITH HEART FAILURE: DOUBLE-BLIND COMPARISON OF INCREASING DOSES OF DIURETICS AND CAPTOPRIL IN MODERATE HEART FAILUREThe Lancet, 1986
- Clinical efficacy of hydralazine in chronic heart failure: One-year double-blind placebo-controlled studyAmerican Heart Journal, 1984
- Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.Circulation, 1984
- A placebo-controlled trial of captopril in refractory chronic congestive heart failureJournal of the American College of Cardiology, 1983
- Coefficient alpha and the internal structure of testsPsychometrika, 1951